TABLE OF CONTENTS
Volume 17, Issue 4 (April 2003)
Original Manuscripts |
Bio-Technical Methods Sections (BTS) |
Meeting Report |
Spotlight Correspondence |
Correspondence
Spotlight
Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL FREE
C A Schiffer, R Hehlmann and R Larson
Leukemia 17: 691-699; doi:10.1038/sj.leu.2402879
Original Manuscripts
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements FREE
C-H Pui, J M Chessells, B Camitta, A Baruchel, A Biondi, J M Boyett, A Carroll, O B Eden, W E Evans, H Gadner, J Harbott, D O Harms, C J Harrison, P L Harrison, N Heerema, G Janka-Schaub, W Kamps, G Masera, J Pullen, S C Raimondi, S Richards, H Riehm, S Sallan, H Sather, J Shuster, L B Silverman, M G Valsecchi, E Vilmer, Y Zhou, P S Gaynon and M Schrappe
Leukemia 17: 700-706; doi:10.1038/sj.leu.2402883
Immunophenotype CD34 in AML
HLA-DR antigen-negative acute myeloid leukemia FREE
M Wetzler, B K McElwain, C C Stewart, L Blumenson, A Mortazavi, L A Ford, J L Slack, M Barcos, S Ferrone and M R Baer
Leukemia 17: 707-715; doi:10.1038/sj.leu.2402865
Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia FREE
N Panoskaltsis, C D L Reid and S C Knight
Leukemia 17: 716-730; doi:10.1038/sj.leu.2402835
Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML FREE
K Nishii, E Usui, N Katayama, F Lorenzo V, K Nakase, T Kobayashi, H Miwa, M Mizutani, I Tanaka, K Nasu, H Dohy, T Kyo, M Taniwaki, T Ueda, K Kita and H Shiku
Leukemia 17: 731-737; doi:10.1038/sj.leu.2402871
Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci FREE
S Gesk, J I Martín-Subero, L Harder, B Luhmann, B Schlegelberger, M J Calasanz, W Grote and R Siebert
Leukemia 17: 738-745; doi:10.1038/sj.leu.2402884
Apoptosis in CLL
Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia FREE
C Campàs, M Dalmau, B Montaner, M Barragán, B Bellosillo, D Colomer, G Pons, R Pérez-Tomás and J Gil
Leukemia 17: 746-750; doi:10.1038/sj.leu.2402860
Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype FREE
S Moisan, M Demers, J Mercier, T Magnaldo, E F Potworowski and Y St-Pierre
Leukemia 17: 751-759; doi:10.1038/sj.leu.2402870
Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors FREE
M Feuring-Buske, B Gerhard, J Cashman, R K Humphries, C J Eaves and D E Hogge
Leukemia 17: 760-763; doi:10.1038/sj.leu.2402882
The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma FREE
P W B Derksen, D J J de Gorter, H P Meijer, R J Bende, M van Dijk, H M Lokhorst, A C Bloem, M Spaargaren and S T Pals
Leukemia 17: 764-774; doi:10.1038/sj.leu.2402875
Myeloma
Thalidomide as initial therapy for early-stage myeloma FREE
S V Rajkumar, M A Gertz, M Q Lacy, A Dispenzieri, R Fonseca, S M Geyer, N Iturria, S Kumar, J A Lust, R A Kyle, P R Greipp and T E Witzig
Leukemia 17: 775-779; doi:10.1038/sj.leu.2402866
Bio-Technical Methods Sections (BTS)
A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia FREE
A van Stijn, A Kok, M A van der Pol, N Feller, G M J M Roemen, A H Westra, G J Ossenkoppele and G J Schuurhuis
Leukemia 17: 780-786; doi:10.1038/sj.leu.2402885
Appendix: Method In Focus
Multiparameter flow cytometric quantification of apoptosis-related protein expression FREE
A van Stijn, A Kok, M A van der Pol, N Feller, G M J M Roemen, A H Westra, G J Ossenkoppele and G J Schuurhuis
Leukemia 17: 787-788; doi:10.1038/sj.leu.2402886
Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies FREE
I S Lossos, D K Czerwinski, M A Wechser and R Levy
Leukemia 17: 789-795; doi:10.1038/sj.leu.2402880
Appendix: Method In Focus
Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies FREE
R Levy
Leukemia 17: 796-797; doi:10.1038/sj.leu.2402881
Meeting Report
'Ponte di Legno' Working Group – Report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April – 1 May 2002 FREE
H Gadner, O A Haas, G Masera, C-H Pui and M Schrappe
Leukemia 17: 798-803; doi:10.1038/sj.leu.2402872
Spotlight Correspondence
Intramuscular edema as a complication of treatment with imatinib FREE
C Shimazaki, N Ochiai, R Uchida, S-I Fuchida, A Okano, E Ashihara, T Inaba, N Fujita and M Nakagawa
Leukemia 17: 804-805; doi:10.1038/sj.leu.2402868
G-CSF for Imatinib-induced neutropenia FREE
D Heim, M Ebnöther, S Meyer-Monard, D Tsakiris, M Linn, A Tichelli and A Gratwohl
Leukemia 17: 805-807; doi:10.1038/sj.leu.2402869
Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment FREE
B Royer-Pokora, B Hildebrandt, A Redmann, C Herold, R Kronenwett, R Haas, M Drechsler and C Wieland
Leukemia 17: 807-810; doi:10.1038/sj.leu.2402877
Correspondence
Cost–effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation FREE
C Chabannon, A-G Le Corroller, F Viret, C Eillen, C Faucher, J-P Moatti, P Viens, N Vey, A-C Braud, G Novakovitch, P Ladaique, A-M Stoppa, J Camerlo, D Genre, D Maraninchi and D Blaise
Leukemia 17: 811-813; doi:10.1038/sj.leu.2402867
MYC is not overexpressed in a case of chronic myelomonocytic leukemia with MYC-containing double minutes FREE
K Paulsson, C Lassen, N Kuric, R Billström, T Fioretos, H J Tanke and B Johansson
Leukemia 17: 813-815; doi:10.1038/sj.leu.2402841
Reduced expression of H19 in bone marrow cells from chronic myeloproliferative disorders FREE
Oliver Bock, Jerome Schlué and Hans Kreipe
Leukemia 17: 815-816; doi:10.1038/sj.leu.2402830
Age-related changes of P-glycoprotein-mediated rhodamine 123 efflux in normal human bone marrow hematopoietic stem cells FREE
R T Calado, C G Machado, J J Carneiro, A B Garcia and R P Falcão
Leukemia 17: 816-818; doi:10.1038/sj.leu.2402853
